Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
All News
Headline News
Press Releases
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
24 25 Next >
Viemed Healthcare's Earnings: A Preview
Via Benzinga
Tickers VMD
Montrose Environmental Group Reports Another Record Quarter and Record First Nine Months; Increases 2025 Guidance
From Montrose Environmental Group, Inc.
Via Business Wire
Tickers MEG
Rivian Releases Third Quarter 2025 Financial Results
From Rivian Automotive, Inc.
Via Business Wire
Tickers RIVN
Lumentum Announces First Quarter of Fiscal Year 2026 Financial Results
From Lumentum
Via Business Wire
Tickers LITE
A Look Into Ibotta Inc's Price Over Earnings
Via Benzinga
Tickers IBTA
Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work
From Catalyst Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers CPRX
PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance
From PROCEPT BioRobotics
Via GlobeNewswire
Tickers PRCT
ARC Restoration Highlights Critical Fire Damage Board-Up Services to Protect Denver Properties
Via Press Advantage
First Acceptance Corporation Reports Operating Results for the Three and Nine Months Ended September 30, 2025
Via ACCESS Newswire
Tickers FACO
Niagen Bioscience, Inc. Reports Third Quarter 2025 Financial Results and Reaffirms Increased Full Year Outlook
From Niagen Bioscience, Inc
Via Business Wire
Tickers NAGE
Westlake Announces Pricing of $1.2 Billion Offering of Senior Notes
From Westlake Corporation
Via Business Wire
Tickers WLK
Flywire Reports Third Quarter 2025 Financial Results
From Flywire Corporation
Via GlobeNewswire
Tickers FLYW
$1000 Invested In Expedia Group 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Tickers EXPE
Amgen Crushes Third-Quarter Expectations On The Back Of Two Blockbusters
Via Investor's Business Daily
Topics Earnings
Tickers AMGN
Exposures Financial
Perdoceo Education Corporation Reports Third Quarter and Year to Date 2025 Results
From Perdoceo Education Corporation
Via Business Wire
Tickers PRDO
Bruker Announces Quarterly Common Stock Dividend and Preferred Stock Dividend
From Bruker Corporation
Via Business Wire
Tickers BRKR BRKRP
Arcturus Therapeutics to Attend Upcoming Investor Conferences
From Arcturus Therapeutics Holdings Inc.
Via Business Wire
Tickers ARCT
Mirum Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
From Mirum Pharmaceuticals, Inc.
Via Business Wire
Tickers MIRM
Tempus Reports Third Quarter 2025 Results
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Advanced Energy Reports Third Quarter 2025 Results
From Advanced Energy Industries, Inc.
Via Business Wire
Tickers AEIS
Stoke Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
From Stoke Therapeutics, Inc.
Via Business Wire
Tickers STOK
Gulfport Energy Reports Third Quarter 2025 Financial and Operating Results
From Gulfport Energy Corporation
Via Business Wire
Tickers GPOR
NetApp Hosts Second Quarter of Fiscal Year 2026 Financial Results Webcast
From NetApp
Via Business Wire
Tickers NTAP
Triad Business Bank (OTC Pink – “TBBC”), November 4, 2025, Announces Unaudited Third Quarter 2025 Results
From Triad Business Bank
Via Business Wire
Align Technology to Speak at Upcoming Financial Conferences
From Align Technology, Inc.
Via Business Wire
Tickers ALGN
Cirrus Logic Reports Record Fiscal Second Quarter Revenue of $561.0 Million
From Cirrus Logic, Inc.
Via Business Wire
Tickers CRUS
Personalis Reports Third Quarter 2025 Financial Results
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Schneider National, Inc. announces participation in upcoming conference
From Schneider SNDR
Via Business Wire
Tickers SNDR
Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update
From Alvotech
Via GlobeNewswire
Tickers ALVO
Ultragenyx Announces Sale of a Portion of Future North American Royalties on Crysvita® (burosumab) for $400 Million to OMERS Life Sciences
From Ultragenyx Pharmaceutical Inc.
Via GlobeNewswire
Tickers RARE
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.